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Recent epidemiologic studies have shown a significant
rise in the prevalence of type 2 diabetes worldwide,
resulting in increased burdens on individuals and health
care systems [1,2]. This disease creates huge social,
economic, and health problems, caused mainly by
diabetic macro- and microvascular complications [2,3].
The frequent coexistence of diabetic macro- and
microangiopathy was described decades ago [4-6].
For macroangiopathy, several measures of subclinical
atherosclerosis have been developed as surrogate
measures of cardiovascular disease (CVD) [7-11].
Atherosclerosis consists of two distinct processes: a
structural process (atherosis) and a functional process
(sclerosis) [12]. Common carotid artery intima-media
thickness (CCA-IMT), ankle-brachial index (ABI), and
carotid plaque presence are considered parameters of
structural changes in atherosclerosis whereas brachial-
ankle pulse wave velocity (baPWV) is a convenient
measure of functional changes in atherosclerosis [13].
Similar to subclinical atherosclerosis, diabetic
microangiopathy is associated with CVD risk in type 2
diabetic patients [14-16].
Such evidence is supported by a “common mechanism”
for the development of macro- and microangiopathy in
type 2 diabetes [17-20]. Several studies have evaluated
the association between macroangiopathy and diabetic
retinopathy [20-24]. However, these associations have
not been adequately explored, particularly in the Korean
population.
In this study, we evaluated the association between
CCA-IMT, baPWV, carotid plaque, and peripheral
arterial disease (PAD) as indicators of macroangiopathy,
and diabetic retinopathy as an indicator of micro-
angiopathy in type 2 diabetic patients.
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Objectives: We evaluated the association between common carotid artery intima-media thickness (CCA-IMT), brachial-
ankle pulse wave velocity (baPWV), carotid plaque, and peripheral arterial disease (PAD) as indicators of
macroangiopathy and diabetic retinopathy as an indicator of microangiopathy in type 2 diabetic patients.
Methods: We analyzed 605 type 2 diabetic patients registered at a public health center in Korea. Following overnight
fasting, venous blood and urine samples were collected and analyzed. The CCA-IMT, levels of carotid plaque, baPWV,
and ankle-brachial index (ABI) of the subjects were assessed. We used non-mydriatic fundus photography to diagnose
diabetic retinopathy. Multiple logistic regression analyses were used to evaluate the association between
macroangiopathy and diabetic retinopathy. CCA-IMT and baPWV were divided into tertiles: CCA-IMT, 0.39 to 0.65 mm,
0.66 to 0.78 mm, and 0.79 to 1.30 mm; baPWV, 9.9 to 15.8 m/s, 15.9 to 18.9 m/s, and 19.0 to 38.0 m/s.
Results: The association between baPWV and diabetic retinopathy remained significant after adjustment, with an increasing
odds ratio (OR) in the second tertile (OR, 2.41; 95% confidence interval [CI], 1.27 to 4.55) and the third tertile (OR, 4.63;
95% CI, 2.33 to 9.21). No significant differences were observed in carotid plaque, PAD, and each tertile of CCA-IMT.
Conclusions: BaPWV was associated with diabetic retinopathy, while CCA-IMT, carotid plaque, and PAD were not. This
study suggests that the association between macroangiopathy and microangiopathy may be attributable to functional
processes rather than structural processes within the vascular system.
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I. Subjects
The study population consisted of 1275 type 2 diabetic
patients registered at a public health center of Seo-gu,
Gwangju, and Gokseong-gun, Jeollanamdo, Korea. The
subjects were participants in the surveys of the Seo-gu
study (conducted between November 2008 and
December 2008), and the Gokseong-gun study
(conducted between June 2009 and November 2009).
In total, 1275 eligible subjects (Seo-gu: 681,
Gokseong-gun: 594) were invited by telephone to
participate. Of these, 709 (Seo-gu: 327, Gokseong-gun:
382) underwent clinical examinations following
interviews. The response rate for the study was 55%
(Seo-gu: 48.0%, Gokseong-gun: 64.3%). Ten patients
who did not provide blood samples and twenty-six who
did not provide urine samples were excluded from the
study. Sixty-eight patients had no HbA1c, CCA-IMT,
carotid plaque, baPWV, history of diabetic duration, or
fundoscopic outcome and were excluded from the
analysis. After excluding these patients, a total of 605
patients (Seo-gu: 290, Gokseong-gun: 315) participated
in the study.
The study protocol was approved by the Institutional
Review Board of Chonnam National University
Hospital, and informed consent was obtained from each
subject. 
II. Methods
A well-trained examiner interviewed the patients using
a questionnaire that included items on smoking status,
diabetic duration, anti-diabetic medication use, anti-
hypertension medication use, and a history of past
illnesses. 
Anthropometric measurements, including weight,
height, and waist measurements, were obtained using
standard techniques. The body mass index (BMI) was
calculated using the following formula: weight
(kg)/height
2 (m
2). Blood pressure was measured on the
right upper arm using a mercury sphygmomanometer
(Baumanometer; WA Baum Co., Inc., Copiague, NY,
USA) with an appropriately sized cuff after subjects had
rested at least 10 min in a sitting position. The first
appearance (phase I) and disappearance (phase V) of
Korotkoff sounds were used to define systolic and
diastolic blood pressure, which was read to the nearest 2
mmHg. Two consecutive measurements of systolic and
diastolic blood pressure were taken in 5 minutes
intervals, and the average was used in the analysis. 
All laboratory specimens were taken following
overnight fasting. The serum was separated onsite and
stored at -70 C until further analysis. All serum samples
were examined using an automatic analyzer (Hitachi-
7600, Hitachi Ltd, Tokyo, Japan). HbA1c was measured
by high-performance liquid chromatography (HPLC)
using the Variant II (Bio-Rad, Hercules, CA, USA).
Total cholesterol, high-density lipoprotein (HDL)
cholesterol, and triglyceride concentrations were
analyzed using enzymatic methods. Low-density
lipoprotein (LDL) cholesterol was estimated as proposed
by Friedewald et al. [25], except when triglyceride levels
exceeded 400 mg/dL. In such instances, the data were
treated as missing. 
Kidney function was assessed using the estimated
glomerular filtration rate (eGFR), which was calculated by
the Modification of Diet in Renal Disease (MDRD)
formula as follows [26]: 186.3  (serum creatinine-
1.154) (age-0.203) 0.742 (if female), with the serum
creatinine concentration expressed in mg/dL.
Non-mydriatic digital images of the retina of each eye
were taken using a retinal camera (TRC-NW200,
Topcon Co., Japan). Retinopathy was considered present
if any characteristic lesions as defined by the Early
Treatment Diabetic Retinopathy Study (ETDRS)
severity scale were present (microaneurysms,
hemorrhages, cotton wool spots, intraretinal micro-
vascular abnormalities, hard exudates, and new retinal
vessels). If the ETDRS severity score was 10, the patient
was defined as having diabetic retinopathy [27].
The CCA-IMT and the presence of carotid plaques
were assessed by physicians using high-resolution mode
B ultrasonographic scans of the carotid arteries
(SonoAce 9900, Medison, Korea) with an electrical
linear array transducer (7.5 MHz). The CCA-IMT was
defined as the distance from the leading edge of the first
echogenic line to the second echogenic line, which
indicated the media-adventitia interface. Images of the
thickest point within 10 mm from the carotid bulb to the
CCA were saved as CCA-IMT, and then measured using
SigmaScan Pro version 5.0.0 (Systat Software Inc.,
Chicago, IL, USA).
The examiners evaluated the CCA, carotid bulb, and
internal carotid artery to determine the levels of carotid
plaque. Protrusions into the lumen that were 100%
thicker than the nearest area were defined as plaques. If
the plaque was the thickest point, the distance to the
nearest point without plaques was defined as the CCA-
IMT. The presence of carotid plaques was recorded if at :POH8PPO:VOFUBM
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least one lesion was detected in six segments.
After a minimum 5 minutes rest period, the baPWV
and ABI were calculated automatically in the supine
position using the VP-1000 system (Colin Co., Komaki,
Japan) with cuffs around both arms and ankles. If any of
the ABIs were < 0.9, the patient was defined as having
PAD.
III. Statistical Analyses
Data are provided as the mean  standard deviation
(SD) for continuous variables, the percentage for
categorical variables, and the median (interquartile
range) for triglyceride and baPWV. An independent
sample t-test or Mann-Whitney U test was used to
examine significant differences in the mean values
between the two groups, and a chi-square test was used
to examine differences in the frequency. The
associations between CCA-IMT, baPWV, and clinical
characteristics were examined using partial correlation,
controlling for age and sex. To evaluate the association
between the surrogate of macroangiopathy (CCA-IMT,
baPWV, carotid plaque, and PAD) and diabetic
retinopathy, different models were constructed using
multiple logistic regression analyses by adjusting for
confounding risk variables (age, sex, duration of
diabetes, HbA1c, total cholesterol (TC), log-transformed
triglycerides, HDL cholesterol, eGFR, BMI, and history
of hypertension). These confounding risk variables were
selected through a literature review [22-24]. Because
there is no clear cut-point for categorization, CCA-IMT
and baPWV were divided into tertiles: CCA-IMT, 0.39
to 0.65 mm, 0.66 to 0.78 mm, and 0.79 to 1.30 mm;
baPWV, 9.9 to 15.8 m/s, 15.9 to 18.9 m/s, and 19.0 to
38.0 m/s.
Statistical analyses were performed with the SPSS
version 19.0 (SPSS Inc, Chicago, IL, USA). A level of p
< 0.05 was accepted as statistically significant.
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Table 1 summarizes the general characteristics of the
study groups with and without retinopathy. The presence
of diabetic retinopathy was confirmed in 114 (18.8%) of
the 605 patients who were eligible to take part in the
study. The mean age of the subjects with diabetic
retinopathy was significantly lower compared to subjects
without diabetic retinopathy. In addition, the response
rate of the Gokseong-gun study (64.3%) was higher than
that of the Seo-gu study (48.0%), and a significant mean
age difference existed between the two regions.
However, the mean age of the subjects with diabetic
retinopathy was significantly lower compared to subjects
without diabetic retinopathy in each of the two regions.
The stratified analysis also showed that there was no
evidence of effect modification by region (data not
shown). The mean values of HbA1c and the duration of
diabetes were significantly higher among subjects with
diabetic retinopathy compared to subjects without
diabetic retinopathy. The baPWV was higher in subjects
with diabetic retinopathy, but this was not statistically
Table 1. General characteristics of the study group with and without retinopathy
Variables Without retinopathy (n=491) With retinopathy (n=114) p-value
2
Men (%)
Age (y)
Duration of diabetes (y)
Height (cm)
Weight (kg)
Body mass index (kg/m
2)
Total cholesterol (mg/dL)
Triglycerides (mg/dL)
1
HDL cholesterol (mg/dL)
HbA1c (%)
eGFR (mL/min/1.73 m
2)
Hypertension (%)
PAD (%)
CCA-IMT (mm)
Carotid plaques (%)
baPWV (m/s)
1
0.144 (29.3)
68.7  9.50
7.7  7.20
154.2  8.50
58.8  10.1
24.7  3.80
193.7  43.1
153.0 (103.2-228.2)
47.3  11.1
7.3  1.50
65.3  15.6
0258 (52.5)
0.052 (10.6)
0.76  0.42
0.236 (48.1)
017.1 (14.9-19.9)
0.039 (34.2)
64.4  10.9
12.9  9.40
155.4  8.10
57.6  9.70
23.8  3.50
196.4  48.7
145.7 (99.9 -203.4)
47.7  12.7
8.2  1.80
65.1  17.8
0.054 (47.4)
0.010 (8.8)
0.71  0.14
0.060 (52.6)
0.17.7 (15.8-20.5)
<0.307
<0.001
<0.001
<0.295
<0.238
<0.035
<0.558
<0.320
3
<0.729
<0.001
<0.909
<0.319
<0.564
<0.216
<0.380
<0.072
3
HDL: high-density lipoprotein, eGFR: estimated glomerular filtration rate, PAD: peripheral arterial disease, CCA-IMT: common carotid artery intima-
media thickness, baPWV: brachial-ankle pulse wave velocity.
All values are given as n (%) or meanstandard deviation.
1 Values are log transformed and given as median(interquartile range), 
2 p-value, as determined by the t-test or chi-square test as appropriate, 
3 p-value,
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significant. 
The associations between CCA-IMT, baPWV, and
clinical characteristics are presented in Table 2. The
CCA-IMT was not correlated with clinical character-
istics, while baPWV was significantly correlated with
BMI (r=-0.158, p<0.001) and triglycerides (r=0.131,
p=0.001).
The odds ratios (ORs) for diabetic retinopathy
according to the CCA-IMT levels are listed in Table 3.
When adjusted for other covariates (i.e., sex, age,
duration of diabetes, HbA1c, TC, log-transformed
triglycerides (logTG), HDL, eGFR, BMI, and history of
HTN), the CCA-IMT was not significantly associated
with diabetic retinopathy.
The ORs for diabetic retinopathy according to baPWV
levels are listed in Table 3. Compared to the first tertile,
crude ORs (95% confidence interval [CI]) for retinopathy
were 1.45 (0.85 to 2.47) for the second tertile and 1.93
(1.16 to 3.24) for the third tertile. Adjustment for age and
sex increased ORs (95% CI) for retinopathy: 2.48 (1.37
to 4.49) for the second tertile and 4.44 (2.38 to 8.31) for
the third tertile. Further adjustment for other covariates
(Model 2) did not change the association.
The ORs for diabetic retinopathy according to carotid
plaques and PAD are listed in Table 3. When adjusted
for all covariates (Model 2), the carotid plaques and PAD
were not significantly associated with diabetic
retinopathy.
%*4$644*0/
The purpose of this study was to determine the
association between macroangiopathy (CCA-IMT,
baPWV, carotid plaque, and PAD) and diabetic
retinopathy. We found that baPWV is significantly
associated with diabetic retinopathy, whereas CCA-IMT,
carotid plaque, and PAD are not.
There was no significant association between CCA-
IMT and diabetic retinopathy among type 2 diabetic
patients after adjusting for cardiovascular risk factors.
These results are consistent with the findings of the
Cardiovascular Health Study (CHS) [21]. However, the
Chennai Urban Rural Epidemiology Study (CURES-2)
and the Atherosclerosis Risk In Communities (ARIC)
study reported a positive relationship between CCA-
IMT and diabetic retinopathy [22,28]. We did not
observe an independent association between carotid
plaque, PAD, and diabetic retinopathy, whereas a
positive relationship has previously been observed
[20,29]. However, carotid plaque and PAD have been
shown not to be significantly associated with diabetic
retinopathy in some studies [30-32]. Selective survival
may provide a potential explanation for these discrepant
results. Severe atherosclerosis and retinopathy in
diabetic patients were both associated with an increased
risk of death, which may have resulted in individuals
with these conditions being less likely to be examined
Table 2. Association between CCA-IMT, baPWV and
clinical characteristics
Variables
CCA-IMT
Correlation
coefficient
1 p-value
baPWV
Correlation
coefficient
1 p-value
Duration of diabetes
Body mass index
Total cholesterol
Triglycerides
HDL cholesterol
HbA1c
eGFR
-0.059
-0.005
0.020
-0.013
-0.052
-0.071
-0.009
0.147
0.912
0.618
0.750
0.202
0.080
0.827
0.018
-0.158
0.074
0.131
0.007
0.059
-0.024
0.663
<0.001
0.068
0.001
0.871
0.146
0.557
CCA-IMT: common carotid artery intima-media thickness, 
baPWV: brachial-ankle pulse wave velocity, HDL: high density
lipoprotein, eGFR: estimated glomerular filtration rate.
1 partial correlation coefficient adjusted for sex and age.
Table 3. Odds ratios for diabetic retinopathy according to CCA-IMT level, baPWV level, carotid plaque, PAD
Variables Range
Crude OR 
(95% CI)
Model 1
1 OR 
(95% CI)
Model 2
2 OR 
(95% CI)
p-value for trend
in Model 2
CCA-IMT (mm)
Tertile 1  
Tertile 2 
Tertile 3 
baPWV (m/s)
Tertile 1  
Tertile 2 
Tertile 3  
Carotid plaque 
PAD
0.39, 0.65
0.66, 0.78
0.79, 1.30
9.9, 15.8
15.9, 18.9
19.0, 38.0
No vs yes
No vs yes
1.00
0.86 (0.53, 1.40)
0.65 (0.39, 1.08)
1.00
1.45 (0.85, 2.47)
1.93 (1.16, 3.24)
1.20 (0.80, 1.80)
0.81 (0.40, 1.65)
1.00
1.12 (0.67, 1.86)
0.91 (0.53, 1.58)
1.00
2.48 (1.37, 4.49)
4.44 (2.38, 8.31)
1.43 (0.93, 2.20)
1.01 (0.49, 2.10)
1.00
1.16 (0.67, 2.02)0
1.06 (0.59, 1.90)0
1.00
2.41 (1.27, 4.55)0
4.63 (2.33, 9.21)0
1.20 (0.75, 1.91)0
0.771 (0.34, 1.73)
0.844
<0.001
CCA-IMT: common carotid artery intima-media thickness, baPWV: brachial-ankle pulse wave velocity, PAD: peripheral arterial disease, OR: odds ratio,
CI: confidence interval.
1 Adjusted for age and sex, 
2 Adjusted for age, sex, duration of diabetes, HbA1c, TC, log-transformed triglycerides, HDL cholesterol, eGFR, BMI, and
history of hypertension. :POH8PPO:VOFUBM
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than patients without these conditions [33]. The other
potential reasons for the discrepant results may include
different sample sizes, population characteristics, the
lower magnification of our images, and the age
distribution of the study population.  
Arterial stiffness is a major contributor to CVD [34],
and baPWV is correlated with the degree of athero-
sclerotic vascular damage [13,35]. The present study
showed that baPWV has a distinct association with
diabetic retinopathy contrary to other surrogates. The
exact mechanisms underlying the association between
atherosclerosis and diabetic retinopathy are poorly
understood. In previous studies, analyses were
conducted separately according to each surrogate [20,22-
24,29,30]. An integrated theory to explain these
observed phenomena has not been established. One
possible explanation is that atherosclerosis and diabetic
retinopathy share common risk factors in the causal
pathway [17,18,20,22]. Although the adjustment for
cardiovascular risk factors in our study did not change
the association between surrogates of macroangiopathy
and diabetic retinopathy, the possibility of an effect of
unmeasured variables remained. In the present study,
functional markers such as baPWV were associated with
diabetic retinopathy, but structural markers such as IMT,
carotid plaque, and PAD were not. This suggests that the
association between macroangiopathy and microangio-
pathy may be due to a functional rather than structural
process within the vascular system. 
Interestingly, in the present study, without adjustment,
there was no significant difference in the baPWV
between subjects with diabetic retinopathy and subjects
without diabetic retinopathy (p value=0.072). However,
after adjustment for age and sex, baPWV was
significantly associated with diabetic retinopathy.
Therefore, this phenomenon may result from the positive
confounding effect of age and sex.
This study has several limitations. First, this was a
cross-sectional study. The association between
macroangiopathy and diabetic retinopathy cannot be
taken as a causal relationship. Nonetheless, we believe
that the results may help shed light on the
pathophysiological connections between the develop-
ment and progression of macro- and microangiopathy in
diabetes. Second, the study targets type 2 diabetic
patients who were registered at a public health center in
a certain area and does not represent the general
population across the nation. Third, the mean age of the
subjects with diabetic retinopathy was significantly
lower than that of subjects without diabetic retinopathy.
This phenomenon may be explained by selection bias
due to either selective survival or nonparticipation
(restricted movement). However, we cannot conclude
that this phenomenon resulted from selection bias,
because we did not compare general characteristics of
study participants and nonparticipants. Fourth, we
conducted multiple comparisons among the four
phenotypes of macroangiopathy. However, after post-
hoc multiple comparisons using the Bonferroni
correction, these associations did not change
substantially. Fifth, we used non-mydriatic color digital
images of the retina. The accuracy of this method is
slightly lower than the use of mydriatic color images.
Despite these limitations, this study provides a valuable
contribution, in that we evaluated the association
between multiple phenotypes of macroangiopathy,
including CCA-IMT, carotid plaque, PAD, and baPWV,
and diabetic retinopathy in a single population.
In summary, baPWV is associated with diabetic
retinopathy in type 2 diabetic patients, but CCA-IMT,
carotid plaque, and PAD are not. Additional studies are
required to further evaluate the common pathogenic
mechanisms underlying these associations in Korean
type 2 diabetic patients.
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